Dyadic to Present at Investor Conferences and BPI East

Core Insights - Dyadic International, Inc. is a global biotechnology company focused on scalable production of high-value, precision-engineered functional input proteins for non-therapeutic applications in life sciences, food and nutrition, and industrial biotechnology [1][2] Company Overview - Dyadic utilizes proprietary microbial platforms to produce recombinant proteins, which are sold or licensed to partners across various markets [2] - The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing, forming the foundation of a growing portfolio of commercial and partnered programs [2] Upcoming Events - Joe Hazelton, President & COO of Dyadic, will present at several upcoming conferences, including: - H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025 [1] - BioProcess International BPI East from September 15-18, 2025 [1] - Sidoti Small Cap Investor Event from September 17-18, 2025 [1] - The management team is open to connecting with investors, analysts, and industry partners during these events [1]